drugset / Trial / NCT00015821
Thalidomide in Treating Patients With Myelofibrosis
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of thalidomide in treating patients who have myelofibrosis. Thalidomide may stop the growth of myelofibrosis by stopping blood flow to the cancer cells.
Timeline
- Start
- 2000-05
- Primary completion
- 2007-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thalidomide | Other / unclassified | — | Oral |